We are live on
!
Find out more
Vontobel Holding Portfolio holdings
AUM
$29.1B
1-Year Est. Return
22.79%
This Fund
S&P 500
This Quarter
Est. Return
+12.54%
1 Year Est. Return
+22.79%
3 Year Est. Return
+78.52%
5 Year Est. Return
+85.53%
10 Year Est. Return
–
AUM
$31.4B
AUM Growth
+$3.96B
(+14%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
3.77%
Top 10 Holdings %
Top 10 Hldgs %
30.31%
Holding
1,320
New
233
Increased
363
Reduced
565
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$631M |
| 2 |
AMRZ
Amrize Ltd
AMRZ
|
+$425M |
| 3 |
Ecolab
ECL
|
+$282M |
| 4 |
iShares MSCI India ETF
INDA
|
+$142M |
| 5 |
Aon
AON
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$355M |
| 2 |
PepsiCo
PEP
|
+$228M |
| 3 |
Amazon
AMZN
|
+$204M |
| 4 |
Mastercard
MA
|
+$147M |
| 5 |
Keysight
KEYS
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.62% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Myomo
MYO
$41M
| $58.8K | ﹤0.01% |
27,219
| – | – |
|
1227
GoodRx Holdings
GDRX
$1.03B
| $58.3K | ﹤0.01% |
+11,716
| New | +$50.9K |
|
1228
CALL
Newmont
NEM
$98.5B
| $58.3K | ﹤0.01% |
+1,000
| New | +$53.4K |
|
|
BLDP
1229
Ballard Power Systems
BLDP
$865M
| $57.8K | ﹤0.01% |
36,097
| – | – |
|
|
RPTX
1230
DELISTED
Repare Therapeutics
RPTX
| $55.6K | ﹤0.01% |
40,000
| – | – |
|
1231
3D Systems Corp
DDD
$430M
| $53.5K | ﹤0.01% |
34,750
| – | – |
|
1232
Alector
ALEC
$168M
| $53.2K | ﹤0.01% |
38,000
+8,000
| +27% | +$10K |
|
1233
CALL
Moody's
MCO
$84.2B
| $50.2K | ﹤0.01% |
+100
| New | +$46.3K |
|
1234
Adicet Bio
ACET
$75.3M
| $48.8K | ﹤0.01% |
5,000
+1,250
| +33% | +$13.2K |
|
|
BIOA
1235
BioAge Labs
BIOA
$928M
| $45.4K | ﹤0.01% |
11,000
| – | – |
|
1236
Werewolf Therapeutics
HOWL
$22M
| $43.6K | ﹤0.01% |
40,000
+5,000
| +14% | +$5.15K |
|
1237
CALL
Fortinet
FTNT
$112B
| $42.3K | ﹤0.01% |
+400
| New | +$40.4K |
|
1238
Actinium Pharmaceuticals
ATNM
$26.8M
| $42K | ﹤0.01% |
30,000
| – | – |
|
1239
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.33B
| $40.2K | ﹤0.01% |
+1,200
| New | +$33.7K |
|
|
SGMO
1240
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $39.7K | ﹤0.01% |
73,300
+15,000
| +26% | +$8.91K |
|
1241
Allogene Therapeutics
ALLO
$604M
| $38.4K | ﹤0.01% |
34,000
-151,646
| -82% | -$202K |
|
1242
CALL
Occidental Petroleum
OXY
$54.6B
| $37.8K | ﹤0.01% |
+900
| New | +$37.6K |
|
1243
AdvisorShares Pure US Cannabis ETF
MSOS
$860M
| $37.4K | ﹤0.01% |
15,500
| – | – |
|
|
TERN
1244
DELISTED
Terns Pharmaceuticals
TERN
| $37.3K | ﹤0.01% |
10,000
-4,000
| -29% | -$12.5K |
|
1245
Aclaris Therapeutics
ACRS
$750M
| $36.9K | ﹤0.01% |
26,000
+4,000
| +18% | +$5.41K |
|
1246
Sutro Biopharma
STRO
$398M
| $35.7K | ﹤0.01% |
5,000
| – | – |
|
1247
CALL
Warner Bros
WBD
$63.4B
| $34.4K | ﹤0.01% |
+3,000
| New | +$28K |
|
1248
CALL
Moderna
MRNA
$22.1B
| $33.1K | ﹤0.01% |
+1,200
| New | +$31.6K |
|
1249
Pulmonx
LUNG
$51.5M
| $31.4K | ﹤0.01% |
12,116
| – | – |
|
|
SGMO
1250
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $28.7K | ﹤0.01% |
+53,000
| New | +$31.5K |
|
Similar funds
Vontobel Holding's Q2 2025 Portfolio in Review
As of Q2 2025, Vontobel Holding held 1,320 positions worth $31.4B, up 14% from $27.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Vontobel Holding deployed $1.18B of net new capital in Q2 2025, opening 233 new positions and adding to 363 existing holdings. Its largest new stake was Amrize Ltd: 8,432,693 shares worth $421M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Becton Dickinson, an estimated $355M trimmed.
- Vontobel Holding's largest Q2 2025 buy was Amrize Ltd: 8,432,693 shares worth $421M.
- Vontobel Holding added most to Meta Platforms (Facebook) in Q2 2025, an estimated $631M increase.
- Vontobel Holding's biggest Q2 2025 reduction was Becton Dickinson, cutting an estimated $355M.
- Vontobel Holding fully exited Brown-Forman Class B in Q2 2025, selling an estimated $51.3M.
- Vontobel Holding's ten largest holdings make up 30% of its $31.4B portfolio in Q2 2025.
- Vontobel Holding opened 233 new positions and closed 65 in Q2 2025.
- Vontobel Holding's portfolio value rose 14% quarter-over-quarter to $31.4B.
Based on Vontobel Holding's 13F filing for Q2 2025, filed 23 Jul 2025.